Navigation Links
Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries

CLEVELAND, Ohio, April 17 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products.

Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries.

Johnson & Johnson LLC will have exclusive rights to distribute Simbionix's line of advanced medical simulators in hospitals in Russia and the rest of the CIS.

"We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into Russian hospitals, teaching facilities, and interventional clinics," said Simbionix CEO Gary Zamler. "This agreement ushers in a new era of simulation-based interventional training for the CIS medical community and we are looking forward to a mutually beneficial relationship with all the countries covered by the agreement, as well as with Johnson & Johnson LLC."

"In the last year, Simbionix has increased its distribution channels and its presence on the international market," explains Mr. Doron Zilberman, Simbionix's VP of International Sales. "We see Russia as one of the leading markets in the emerging medical world, and our agreement is a sign of Simbionix's success in the international market ..."

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit

    Inbal Mazor
    VP Marketing
    Tel: +972-8-9211177 ext. 222

SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
2. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
3. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
4. Simbionix Launches Innovative Patient-Specific Simulation
5. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
6. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
7. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
8. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
9. Simbionix Increases Product Offerings for OB/GYN Physicians
10. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
11. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
Post Your Comments:
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/23/2015)... , Oct. 23, 2015 Research and ... the "Global Voice Recognition Biometrics Market 2015-2019" ... --> The global voice recognition biometrics ... 2014-2019. --> --> ... has been prepared based on an in-depth market analysis ...
Breaking Biology News(10 mins):